Supporting these findings, Beliën et al. analyzed a large cohort of 192 MS patients and found that CSF CHIT1 was the strongest predictor of early EDSS progression among myeloid biomarkers and histologically localized to lipid-laden microglia within active demyelinating lesions [20]. The gene discussed is CHIT1; the disease is myeloid sarcoma.